EP 1259493 A2 20021127 - Substituted piperazine compounds
Title (en)
Substituted piperazine compounds
Title (de)
Substituierte Piperazin-Verbindungen
Title (fr)
Composés de pipérazine substitués
Publication
Application
Priority
- US 0105606 W 20010222
- US 18418200 P 20000222
- US 18445700 P 20000222
- US 18430600 P 20000222
- US 20639600 P 20000523
- US 20926200 P 20000605
Abstract (en)
[origin: WO0162744A2] Novel compounds of the general formula (I) and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetal's (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.
IPC 1-7
C07D 241/04; C07D 241/08; C07D 241/42; C07D 295/108; C07D 317/54; C07D 317/58; A61K 31/495; A61K 31/498; A61K 31/4995; A61P 9/00
IPC 8 full level
C07D 295/14 (2006.01); A01N 1/02 (2006.01); A61K 9/08 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/407 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/498 (2006.01); A61K 31/5377 (2006.01); A61P 9/00 (2006.01); A61P 9/04 (2006.01); A61P 9/06 (2006.01); A61P 9/10 (2006.01); A61P 21/00 (2006.01); A61P 39/06 (2006.01); C07D 241/04 (2006.01); C07D 241/08 (2006.01); C07D 241/36 (2006.01); C07D 241/42 (2006.01); C07D 295/15 (2006.01); C07D 317/54 (2006.01); C07D 317/58 (2006.01); C07D 403/12 (2006.01); C07D 487/08 (2006.01)
CPC (source: EP KR)
A61K 31/495 (2013.01 - KR); A61P 9/00 (2017.12 - EP); A61P 9/02 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/06 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 39/06 (2017.12 - EP); C07D 241/04 (2013.01 - EP KR); C07D 241/08 (2013.01 - EP KR); C07D 241/42 (2013.01 - EP); C07D 295/088 (2013.01 - KR); C07D 295/15 (2013.01 - EP KR); C07D 317/54 (2013.01 - EP); C07D 317/58 (2013.01 - EP KR); C07D 405/06 (2013.01 - KR)
Citation (search report)
See references of WO 0162744A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0162744 A2 20010830; WO 0162744 A3 20020207; AR 029229 A1 20030618; AU 2001238623 B2 20040923; AU 3862301 A 20010903; BR 0108592 A 20040629; CA 2400176 A1 20010830; CA 2400176 C 20090428; CA 2657986 A1 20010830; CN 1404471 A 20030319; EP 1259493 A2 20021127; IL 151178 A0 20030410; JP 2003531116 A 20031021; JP 2007211009 A 20070823; JP 3980885 B2 20070926; KR 100595942 B1 20060703; KR 20020079893 A 20021019; MX PA02008213 A 20040405; NO 20023954 D0 20020820; NO 20023954 L 20020930; NO 324837 B1 20071217; NZ 520782 A 20040326; TW I236471 B 20050721
DOCDB simple family (application)
US 0105606 W 20010222; AR P010100804 A 20010222; AU 2001238623 A 20010222; AU 3862301 A 20010222; BR 0108592 A 20010222; CA 2400176 A 20010222; CA 2657986 A 20010222; CN 01805442 A 20010222; EP 01911085 A 20010222; IL 15117801 A 20010222; JP 2001562526 A 20010222; JP 2007005347 A 20070115; KR 20027011014 A 20020822; MX PA02008213 A 20010222; NO 20023954 A 20020820; NZ 52078201 A 20010222; TW 90104080 A 20010413